This study evaluated the factors affecting the development of malignant mesothelioma, proposed a new idea of SMO, GLI1, and immune cells as possible indicators of personalized immunotherapy and prognosis, and provided an experimental basis for finding new gene targets for mesothelioma. Here, SMO is linked to malignant mesothelioma.